Are you struggling to maintain control over your weight? Rejuve Anti Aging offers a treatment option featuring Semaglutide & Tirzepatide therapies to help kickstart your journey towards achieving your goals.
Semaglutide and tirzepatide are game-changing medications, particularly for weight management and metabolic health. Both belong to a class of drugs called GLP-1 receptor agonists (semaglutide) or dual GIP/GLP-1 receptor agonists (tirzepatide).
Ozempic® (Semaglutide) and Mounjaro® (Tirzepatide) have FDA approval based on rigorous clinical trials demonstrating safety and efficacy
Thousands of patients have seen significant weight loss by following this simple, weekly regimen.
Semaglutide & Tirzepatide are trusted medications with well-established safety profiles and backed by extensive studies.
Weekly injections by our nurses mean you can focus on your health without daily reminders.
These treatments mimic the glucagon-like peptide-1 (GLP-1) hormone, which influences hunger and food intake control in the brain resulting in appetite suppression and delayed stomach emptying. Additionally, these medications stabilize insulin levels allowing your body to access and utilize fat reserves more effectively for weight loss.
Our promise: the price you see for any medication is the price you’ll pay—no hidden fees or surprises—regardless of the dosage prescribed. Every single time. Our mission is making metabolic health accessible and affordable for everyone. That’s why we guarantee that the cost of your medication will remain consistent, from your very first month to your last. No unexpected increases, no exceptions.
Nat Med. 2024 Jul;30
At 208 weeks, semaglutide was associated with mean reduction in weight, waist circumference, and waist-to-height ratio.
Journal of Translational Medicine
Several evidence demonstrated that GLP1s reduce the risk of dementia by improving memory, learning, and overcoming cognitive impairment.
The Journal of the American Medical Association
Findings based on data from 17,600 participants with preexisting cardiovascular disease
Weight Loss:
Effective Fat Loss: Both drugs are highly effective at promoting significant weight loss by reducing appetite, enhancing feelings of fullness, and slowing gastric emptying.
Sustained Results: Many individuals experience long-term, sustainable weight management when paired with healthy lifestyle changes.
Metabolic Health Improvements:
Better Blood Sugar Control: Originally designed for type 2 diabetes, these medications lower blood sugar levels by increasing insulin sensitivity and reducing glucose production in the liver.
Reduction in Insulin Resistance: They improve how the body responds to insulin, a critical factor in managing metabolic syndrome and type 2 diabetes.
Heart Health:
Cardiovascular Benefits: Clinical studies have shown reductions in major adverse cardiac events, including heart attack, stroke, and cardiovascular death, in individuals with type 2 diabetes.
Lower Blood Pressure and Cholesterol: Both medications contribute to improved blood pressure and lipid profiles, further supporting heart health.
Convenience and Flexibility:
Once-Weekly Dosing: These medications are typically administered as a simple, once-weekly injection, making them easy to incorporate into your routine.
Customizable Dosages: Dosages can be tailored to meet individual needs, ensuring optimal results.
Additional Benefits:
Improved Quality of Life: Many individuals report increased energy levels, better mobility, and enhanced confidence as they achieve their health goals.
Potential Liver Health Support: Research suggests a reduction in markers of fatty liver disease, which is common in individuals with obesity or metabolic disorders.
Tirzepatide-Specific Advantages:
Dual Mechanism of Action: Tirzepatide targets both GIP and GLP-1 receptors, potentially leading to even greater improvements in weight loss and blood sugar control compared to semaglutide.
Enhanced Weight Loss Outcomes: Studies indicate that tirzepatide may offer superior weight loss results for certain individuals.
Glucagon-like peptide-1 (GLP-1) medications, also known as GLP-1 receptor agonists (GLP-1RAs) or incretin mimetics, are a class of drugs that mimic the action of the hormone GLP-1. GLP-1 is a natural hormone that helps regulate blood sugar, appetite, and digestion. GLP-1 medications are used to treat type 2 diabetes and obesity.
GLP-1 medications work by: Stimulating the pancreas to produce more insulin, Slowing down digestion, Reducing the amount of sugar the liver makes, and Reducing appetite.
This medicine is given as a shot under the skin (subcutaneous) of your stomach, thighs, or upper arm.
Both Semaglutide and Tirzepatide begin to show effects relatively early, but the timeline for noticeable results can vary depending on the individual and the purpose of treatment.
Semaglutide
Tirzepatide
Factors That Affect the Timeline:
While you may notice early effects like reduced hunger, sustained results, particularly for weight loss, require several weeks and consistent treatment.
Semaglutide and Tirzepatide are effective medications, but they can have side effects. Most are mild and manageable, but some can be more serious. Here’s an overview:
Common side effects include nausea, vomiting, diarrhea, and abdominal pain. Less common but more severe side effects can include hypoglycemia (low blood sugar), kidney problems, pancreatitis, and diabetic retinopathy complications.
Managing Side Effects
If you miss a dose, take it as soon as you remember, as long as it’s within 5 days of your scheduled dose. If more than 5 days have passed, skip the missed dose and resume your normal schedule.
While not required, combining these medications with a balanced, low-calorie diet and regular exercise enhances results.
Limit alcohol, as it can interfere with blood sugar control and increase the risk of side effects like nausea.